You鈥檙e about to turn 60, and you鈥檙e fretting. Your mother has had Alzheimer鈥檚 disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer鈥檚, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.
Category:
Published on: 26 Feb 2018
The HCALM Network issues regularly a call for proposals for research projects whose focus is to investigate the relationship between language and access to health care or social services.
Proposals must be e-mailed by Sunday, April 8, 2018.
For all information, click here.
Category:
Published on: 23 Feb 2018
's investment of $150 million in 91社区's Healthy Brains for Healthy Lives (HBHL) and Western University's marks a pivotal step that will unlock the mysteries of the human mind and lay the groundwork for a pan-Canadian network of collaboration that promises to uncover new ways to treat, prevent and cure brain disorders.聽
Published on: 6 Feb 2018
Volume in brain region linked to physiological changes characteristic of AD
New research has drawn a link between changes in the brain鈥檚 anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer鈥檚 disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.
Category:
Published on: 19 Dec 2017
NeuroSGC created to increase volume and quality of cell assays for drug discovery
A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.
The partnership, called NeuroSGC, will initially focus on Parkinson鈥檚 disease and amyotrophic lateral sclerosis (ALS), two of the most common neurodegenerative diseases.
Category:
Published on: 6 Dec 2017
Industry and academia team up for the benefit of people suffering from ALS
A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.
The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.
Category:
Published on: 4 Dec 2017
Senate of Canada recognizes outstanding contributions to the community聽
The Senate of Canada has awarded Alan Evans a Canada 150 medal for his commitment to advancements in Alzheimer鈥檚 disease and palliative care research. He was nominated by , a former research fellow at the Montreal Neurological Institute and Hospital, and Associate Professor of the 91社区 School of Social Work.
Published on: 27 Nov 2017
Grants for Heather Durham, Stefano Stifani and Jay Ross total just over $2 million聽
Three MNI researchers have received grants from the ALS Society of Canada worth a total of more than $2 million. 聽
Category:
Published on: 24 Nov 2017
Brain stimulation can change how much we enjoy and value music
Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.
Category:
Published on: 20 Nov 2017
The Azrieli Centre for Autism Research will foster innovations in therapy and a better understanding of Autism Spectrum Disorder.
A new research centre in Montreal will help lift the shroud of mystery surrounding autism spectrum disorder (ASD), and lead to the development of better diagnostic tools and more effective therapies for people with autism.
Category:
Published on: 23 Oct 2017
A Brilliant Night has donated a total of $1.6 million since 2015
A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.
Category:
Published on: 10 Oct 2017
Research shows how the brain鈥檚 motor signals sharpen our ability to decipher complex sound flows
Whether it is dancing or just tapping one foot to the beat, we all experience how auditory signals like music can induce movement. Now new research suggests that motor signals in the brain actually sharpen sound perception, and this effect is increased when we move in rhythm with the sound.
Category:
Published on: 5 Oct 2017
Research symposium, public education event and ALS walk planned
Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.
Category:
Published on: 13 Sep 2017
Society recognizes scholarly, research and artistic excellence.
Dr. Edith Hamel and Dr. Robert Zatorre have been elected Fellows of the Royal Society of Canada. Election to the academies of the Royal Society of Canada is the highest honour a scholar can achieve in the Arts, Humanities and Sciences.
Category:
Published on: 7 Sep 2017
The Neuro to launch open research publishing platform with F1000
A new partnership between The Neuro and F1000 will create a publishing platform for researchers that will speed the progress of neuroscience discovery.
The Montreal Neurological Institute and Hospital of 91社区 (The Neuro) is partnering with F1000, a provider of support services for researchers, institutes and funders, to create a new open research publishing platform called MNI Open Research ().
Category:
Published on: 30 Aug 2017
Pages
